Evaluation of Antifungal Activity of Silver Nanoparticles on Fusarium oxysporum

authors:

avatar Javad Abkhoo 1 , avatar Naser Panjehkeh 2 , *

Institute of Plant Biotechnology, University of Zabol, Zabol, IR Iran
Department of Plant Protection, Faculty of Agriculture, University of Zabol, Zabol, IR Iran

how to cite: Abkhoo J, Panjehkeh N. Evaluation of Antifungal Activity of Silver Nanoparticles on Fusarium oxysporum. Int J Infect. 2017;4(2):e41126. https://doi.org/10.5812/iji.41126.

Abstract

Background:

Silver nanoparticles (AgNPs) are between 1 nm and 100 nm in size.

Objectives:

Different concentrations of AgNPs were tested in this research to examine antifungal activity on Fusarium oxysporum.

Methods:

Antifungal activity of AgNPs on basis of colony formation was evaluated by in vitro Petri dish measurement.

Results:

Different concentrations of AgNPs inhibit colony formation of F. oxysporum at different levels. As concentration of AgNPs was increased, there was a decrease in colony formation. Silver nanoparticles at the highest concentration (5000 ppm) did not fully inhibit F. oxysporum colony formation. Silver nanoparticles (5000 ppm) and colonize F. oxysporum to decrease to 35% after one hour of exposure, 27% after three hours of exposure, and 24% after five hours of exposure. The antifungal activity of AgNPs to the reduce colony formation was apparent within one hour. The spore extended time exposure to AgNPs from one to five hours significantly reduced colony formation.

Conclusions:

The antifungal activity of AgNPs has a great potential for use in control of fungal spores.

1. Background

Silver Nanoparticles (AgNPs) are between 1 nm and 100 nm in size (1). Until the nineteenth century silver was not considered as an antibacterial agent (2, 3). Since then, antimicrobial properties of silver have been studied and used more than any other inorganic antibacterial (4).

Micromolar concentrations of silver have no harmful effects on humans (5). Therefore, silver has been used for many biological processes and pharmaceutical development of dental materials, grafts (6) and coating materials for medical devices (7). Fungal strains of Fusarium oxysporum soil inhabitants have the ability to live as saprophytes and degrade lignin (8). Many disease-causing strains within complex F. oxysporum to plants, especially in agricultural settings. The use of AgNPs has become more common as technological advances have made it more affordable. It is possible for AgNPs to have serious consequences for the environment (9). One of potential applications is its use in plant disease management. Up to now, limited research evidence on the use of AgNPs for the control of fungal pathogens, has been published (10).

2. Objectives

The aim of this research was to evaluate the antifungal effect of AgNPs on F. oxysporum.

3. Methods

3.1. Fungal Isolate

Fusarium oxysporum, which is a plant pathogenic fungus, was used in this research. Single-spore isolates of F. oxysporum from infected melon plants were collected from the Sistan region.

3.2. Silver Preparation

The seeds of Satureja hortensis were collection from the southern region of Iran (Kerman) and silver preparation was conducted, as described by Mohassel and Pourseyedi (11).

3.3. Inhibition of Colony Formation by Different Concentrations of Silver Nanoparticles

Antifungal activity of AgNPs on basis of colony formation was evaluated by in vitro Petri dish measurement. Fusarium oxysporum was grown in CMA. Conidium cultures were incubated at 28°C for 10 days and 106 spores per mL-1 were diluted with distilled water. Same amount of spore suspension of AgNPs preparation series (1000, 2500 and 5000 ppm) were mixed to a final volume of 1 mL, and water was mixed with distilled water as a control. Ten-milliliter-sample of stock conidia and silver was mixed at 0, 1, 3 and 5 hours after treatment were silver and diluted 100 times with sterile water. Ten microliters of diluted sample in PDA released spores. Four PDA plates were tested at any combination of exposure time and concentration of AgNPs. The number of colonies that had formed on the plates were counted after four days at 28°C. The numbers of colonies of AgNPs treated with a spore suspension on controller were compared to calculate concentration of each AgNPs preparation.

4. Results

4.1. Inhibition of Colony Formation by Different Concentrations of Silver Nanoparticles

Different concentrations of AgNPs inhibited colony formation of F. oxysporum at different levels (Figure 1). As concentration of AgNPs increased, there was decreased colony formation. Silver nanoparticles at the highest concentration (5000 ppm) did not fully inhibit colony formation of F. oxysporum. Silver nanoparticles (5000 ppm) led to a decrease in F. oxysporum colonies to 35% after one hour of exposure, 27% after three hours of exposure, and 24% after five hours of exposure (Figure 2).

Colony Formation of Fusarium oxysporum on PDA Medium, Five Hours Post-Treatment of Spores With Water and Different Concentrations of Silver Nanoparticles (AgNPs)
Colony Formation of Fusarium oxysporum on PDA Medium, Five Hours Post-Treatment of Spores With Water and Different Concentrations of Silver Nanoparticles (AgNPs)

Images were captured after culture plates had been incubated for four days at 28°C.

Colony Formation of Fusarium oxysporum at Different Concentrations of Silver Nanoparticles (AgNPs)
Colony Formation of Fusarium oxysporum at Different Concentrations of Silver Nanoparticles (AgNPs)

Antifungal activity of AgNPs to reduce colony formation was apparent within one hour. Extended exposure to the spores of AgNPs (Figure 2) from one to five hours significantly reduced colony formation (P > 0.05).

5. Discussion

The control of fungal diseases in crops is very important. Recently, efforts to further develop management practices and lower the risks for human safety have been raised. In addition, several studies were carried out to test antifungal activity of AgNPs against plant pathogenic fungi. Results presented in this research confirm that AgNPs has an inhibitory effect on colony of spores of F. oxysporum. Silver nanoparticles may be directly attached to penetrate cell membranes to kill spores (12).

Researchers have used AgNPs, as carriers to deliver various loads of large biological molecules to specific targets. Targeting high-cargo density and concentration of nanoparticles may provide a specific target site and has the least side effects (13).

Introduction of silver in bacterial cells results in a high degree of structural and morphological changes, which can lead to cell death. As AgNPs come in contact with bacteria holds cell wall and cell membrane them (14). Introduction of AgNPs is sufficient to prevent a repeat and to cause cell death. In addition to increasing its effectiveness, when silver comes into contact with the liquid, it leads to an increase in ionized particles’ antibacterial activity (15). This leads to suppression of enzyme and protein expression, which is linked to the ability of cells to produce ATP related to the condition (16). Although it is a different offer for each type of cell, cell membrane components differ greatly, it has been seen that in general, AgNPs with an average size of 10 nm or less indicates that electronic effects, which to increase greatly its antibacterial activity (17). It has been noted that the introduction of AgNPs has synergistic activity with common antibiotics currently used today, such as erythromycin, ampicillin and vancomycin-resistant Staphylococcus aureus (18). Medical equipment, indicate that AgNPs reduces the number of bacteria on the device used (19).

5.1. Conclusion

Antifungal activity of AgNPs has a great potential for use in production of control fungal spores.

Acknowledgements

References

  • 1.

    Demirors AF, van Blaaderen A, Imhof A. A general method to coat colloidal particles with titania. Langmuir. 2010;26(12):9297-303. [PubMed ID: 20334440]. https://doi.org/10.1021/la100188w.

  • 2.

    Oloffs A, Grosse-Siestrup C, Bisson S, Rinck M, Rudolph R, Gross U. Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material. Biomaterials. 1994;15(10):753-8. [PubMed ID: 7986938].

  • 3.

    Tokumaru T, Shimizu Y, Fox CJ. Antiviral activities of silver sulfadiazine in ocular infection. Res Commun Chem Pathol Pharmacol. 1974;8(1):151-8. [PubMed ID: 4368031].

  • 4.

    Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem. 1994;31(2):351-70.

  • 5.

    Berger TJ, Spadaro JA, Chapin SE, Becker RO. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob Agents Chemother. 1976;9(2):357-8. [PubMed ID: 944551].

  • 6.

    Hotta M, Nakajima H, Yamamoto K, Aono M. Antibacterial temporary filling materials: the effect of adding various ratios of Ag-Zn-Zeolite. J Oral Rehabil. 1998;25(7):485-9. [PubMed ID: 9722093].

  • 7.

    Raad ,I, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med. 2002;162(8):871-8. [PubMed ID: 11966337].

  • 8.

    Rodriguez A, Perestelo F, Carnicero A, Regalado V, Perez R, De la Fuente G, et al. Degradation of natural lignins and lignocellulosic substrates by soil-inhabiting fungi imperfecti. FEMS Microbiol Ecol. 1996;21(1):213-9.

  • 9.

    Hogstrand C, Wood CM. The toxicity of silver to marine fish. USA: University of Kentucky; 1996.

  • 10.

    Jo YK, Kim BH, Jung. G. Antifungal activity of silver ions and nanoparticles on phytopathogenic fungi. Plant Dis. 2009;93(2):1037-43.

  • 11.

    Mohasseli T, Pourseyedi S. Antibacterial activity of silver nanoparticles produced by Sesamum indicum seed extract on staphylococcus epidermidis and salmonella typhi. Inter Res J Appl Basic Sci. 2013;6(5):587-91.

  • 12.

    Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346-53. [PubMed ID: 20818017]. https://doi.org/10.1088/0957-4484/16/10/059.

  • 13.

    Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ. Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev. 2008;24(8):604-10. [PubMed ID: 18802934]. https://doi.org/10.1002/dmrr.893.

  • 14.

    Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 2000;26(2):131-8.

  • 15.

    Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52(4):662-8. [PubMed ID: 11033548].

  • 16.

    Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005;71(11):7589-93. [PubMed ID: 16269810]. https://doi.org/10.1128/AEM.71.11.7589-7593.2005.

  • 17.

    Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73(6):1712-20. [PubMed ID: 17261510]. https://doi.org/10.1128/AEM.02218-06.

  • 18.

    Shahverdi AR, Fakhimi A, Shahverdi HQ, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007;3(2):168-71.

  • 19.

    Jain P, Pradeep T. Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng. 2005;90(1):59-63. [PubMed ID: 15723325]. https://doi.org/10.1002/bit.20368.